Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

An analysis of 10 cancer treatment sites revealed that many pediatric patients do not receive care pathway-consistent and CPG-consistent care.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

HealthDay News — Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal ...

Consensus statements on managing childhood dystonia were recently released by a panel of experts in pediatric palliative care.

A financial toxicity tumor board has effectively reduced financial toxicity for cancer patients, researchers say.

The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.

Registered nurse shift length and skill level mix in the previous 7 days influence sickness-related absences in nurse and nursing support staff.

Maintenance with niraparib and bevacizumab can be effective in patients with platinum-sensitive, recurrent ovarian cancer previously treated with a PARP inhibitor.

To develop the combined model, the researchers integrated the imaging-derived radiomics score from the best-performing radiomics model (random forest) with the clinical model.

The cohort study included more than a quarter million men with prostate cancer from routine clinical practice.

The decision to choose systemic adjuvant therapy warrants careful discussion on its benefits and risks,” researchers wrote.